Registration Dossier

Toxicological information

Eye irritation

Currently viewing:

Administrative data

Endpoint:
eye irritation
Remarks:
other: artificial human 3D-Cornea model
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2012
Report Date:
2011

Materials and methods

Principles of method if other than guideline:
In vitro study for assessing ocular irritation of compounds using a human epithelial corneal cell model. The model used is standardized and commercially available (SkinEthic™ Human Corneal Epithelial Model (HCE); SkinEthic, France).
GLP compliance:
yes

Test material

Reference
Name:
Unnamed
Type:
Constituent
Details on test material:
Content: 90.2%

Test animals / tissue source

Species:
other: not applicable - human corneal epithelial model (HCE)
Strain:
other: not applicable - human corneal epithelial model (HCE)

Test system

Vehicle:
other: not applicable - human corneal epithelial model (HCE)
Controls:
other: not applicable - human corneal epithelial model (HCE)
Duration of treatment / exposure:
After an exposure period of 60 minutes, followed by a 16 hours post-treatment incubation period, the cell viability was measured
Observation period (in vivo):
not applicable - human corneal epithelial model (HCE)
Number of animals or in vitro replicates:
not applicable - human corneal epithelial model (HCE)

Results and discussion

In vivo

Results
Irritation parameter:
other: cell viability
Basis:
mean
Time point:
other: 60 minutes followed by a 16 h post-treatment period
Score:
84.62
Max. score:
100
Reversibility:
other: not applicable - human corneal epithelial model (HCE)
Remarks on result:
other: non-irritant - scores in [%] viability

Any other information on results incl. tables

A test substance is predicted to be an ocular irritant if the mean relative tissue viability (%) exposed to the test substance is <50%.

As can be seen from the information in the Table below the test substance tetrasodium hydrogen 2-phosphonatobutane-1,2,4-tricarboxylate was not detected as positive in this test model.

Compound                     Cell viability [%]       Evaluation

Test item                          101.56                 non-irritant

Positive control                    1.50                     irritant

Negative control               100.00               non-irritant

Applicant's summary and conclusion

Interpretation of results:
not irritating
Remarks:
Migrated information
Executive summary:

This in vitro study for assessing ocular irritation of compounds using a human epithelial corneal cell model was performed in 2012. The model used is standardized and commercially available (SkinEthicTM Human Corneal Epithelial Model (HCE); SkinEthic, France).

Undiluted tetrasodium hydrogen 2-phosphonatobutane-1,2,4-tricarboxylate was applied topically to the HCE tissue, i.e. 30 mg per insert (plus 30 µl PBS to moisten and ensure good contact with the skin; three replicates).

After an exposure period of 60 minutes, followed by a 16 hours post-treatment incubation period, the cell viability was 85% (rounded) as measured by a MTT conversion assay.

The results of the concurrent negative (NC, PBS) and positive control (PC, 1H-1,2,4-Triazole-3-thiol) demonstrated the viability (NC) and sensitivity (PC) of the test model.

The results show that tetrasodium hydrogen 2-phosphonatobutane-1,2,4-tricarboxylate is predicted as non-irritant under the conditions of this test method.